Journal ArticleDOI
Development and testing of a general amber force field.
Reads0
Chats0
TLDR
A general Amber force field for organic molecules is described, designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most organic and pharmaceutical molecules that are composed of H, C, N, O, S, P, and halogens.Abstract:
We describe here a general Amber force field (GAFF) for organic molecules. GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most organic and pharmaceutical molecules that are composed of H, C, N, O, S, P, and halogens. It uses a simple functional form and a limited number of atom types, but incorporates both empirical and heuristic models to estimate force constants and partial atomic charges. The performance of GAFF in test cases is encouraging. In test I, 74 crystallographic structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 A, which is comparable to that of the Tripos 5.2 force field (0.25 A) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 A, respectively). In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermolecular energies were compared to MP2/6-31G* results. The RMS of displacements and relative energies were 0.25 A and 1.2 kcal/mol, respectively. These data are comparable to results from Parm99/RESP (0.16 A and 1.18 kcal/mol, respectively), which were parameterized to these base pairs. Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field. The RMS error in relative energies (compared to experiment) is about 0.5 kcal/mol. GAFF can be applied to wide range of molecules in an automatic fashion, making it suitable for rational drug design and database searching.read more
Citations
More filters
Journal ArticleDOI
Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor
Christofer S. Tautermann,Tobias Kiechle,Daniel Seeliger,Sonja Diehl,Eva Wex,Rolf Banholzer,Florian Gantner,Michael P. Pieper,Paola Casarosa +8 more
TL;DR: The long duration of action of the antimuscarinic drug tiotropium and its kinetic subtype selectivity over hM2R are investigated by kinetic mapping of the binding site and the exit channel of hM3R.
Journal ArticleDOI
Comparison of end-point continuum-solvation methods for the calculation of protein-ligand binding free energies.
Samuel Genheden,Ulf Ryde +1 more
TL;DR: The predictions of ligand‐binding affinities from several methods based on end‐point molecular dynamics simulations and continuum solvation, that is, methods related to MM/PBSA and Poisson–Boltzmann and surface area solvation are compared.
Journal ArticleDOI
Structure-Guided Design of a High-Affinity Platelet Integrin αIIbβ3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS
Jieqing Zhu,Jieqing Zhu,Won-Seok Choi,Joshua G. McCoy,Andrea Negri,Jianghai Zhu,Sarasija Naini,Jihong Li,Min Shen,Wenwei Huang,Daniel W. Bougie,Mark Rasmussen,Richard H. Aster,Craig J. Thomas,Marta Filizola,Timothy A. Springer,Barry S. Coller +16 more
TL;DR: A new drug blocks platelet aggregation by interacting with the integrin receptor differently from current drugs that cause adverse side effects, and could have significant advantages over existing drugs, although this still needs to be tested directly in patients.
Journal ArticleDOI
Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
Gerard Minuesa,Steven K. Albanese,Wei Xie,Yaniv Kazansky,Daniel Worroll,Arthur Chow,Alexandra Schurer,Sun Mi Park,Christina Z. Rotsides,James Taggart,Andrea Rizzi,Andrea Rizzi,Levi N. Naden,Timothy Chou,Saroj Gourkanti,Daniel Cappel,Maria C. Passarelli,Maria C. Passarelli,Lauren Fairchild,Lauren Fairchild,Carolina Adura,Fraser Glickman,Jessica Schulman,Christopher Famulare,Minal Patel,Joseph K. Eibl,Gregory M. Ross,Shibani Bhattacharya,Derek S. Tan,Christina S. Leslie,Thijs Beuming,Dinshaw J. Patel,Yehuda Goldgur,John D. Chodera,Michael G. Kharas +34 more
TL;DR: This study finds that the small molecule Ro 08–2750 (Ro) binds directly and selectively to MSI2 and competes for its RNA binding in biochemical assays and provides a framework for targeting RNA binding proteins in cancer.
Journal ArticleDOI
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease.
Cintia A. Menéndez,Fabian Byléhn,Gustavo R. Perez-Lemus,Walter Alvarado,Juan J. de Pablo,Juan J. de Pablo +5 more
TL;DR: The results reveal a higher-affinity, previously unknown binding site localized between the II and III domains of the protein that exerts a pronounced allosteric effect that regulates catalytic site access through surface-loop interactions, thereby inducing a reconfiguration of water hotspots.
References
More filters
Journal ArticleDOI
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Wendy D. Cornell,Piotr Cieplak,Piotr Cieplak,Christopher I. Bayly,Christopher I. Bayly,Ian R. Gould,Ian R. Gould,Kenneth M. Merz,Kenneth M. Merz,David M. Ferguson,David M. Ferguson,David C. Spellmeyer,David C. Spellmeyer,Thomas R. Fox,James W. Caldwell,Peter A. Kollman +15 more
TL;DR: Weiner et al. as mentioned in this paper derived a new molecular mechanical force field for simulating the structures, conformational energies, and interaction energies of proteins, nucleic acids, and many related organic molecules in condensed phases.
Journal ArticleDOI
A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model
TL;DR: In this paper, the authors present an approach to generate electrostatic potential (ESP) derived charges for molecules, which optimally reproduce the intermolecular interaction properties of molecules with a simple two-body additive potential, provided that a suitably accurate level of quantum mechanical calculation is used to derive the ESP around the molecule.
Journal ArticleDOI
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
TL;DR: The first published version of the Merck molecular force field (MMFF) is MMFF94 as mentioned in this paper, which is based on the OPLS force field and has been applied to condensed-phase processes.
Journal ArticleDOI
A new force field for molecular mechanical simulation of nucleic acids and proteins
S. J. Weiner,Peter A. Kollman,David A. Case,U. C. Singh,Caterina Ghio,Giuliano Alagona,Salvatore Profeta,Paul K. Weiner +7 more
TL;DR: In this paper, a force field for simulation of nucleic acids and proteins is presented, which is based on the ECEPP, UNECEPP, and EPEN energy refinement software.
Journal ArticleDOI
How Well Does a Restrained Electrostatic Potential (RESP) Model Perform in Calculating Conformational Energies of Organic and Biological Molecules
TL;DR: In this paper, the authors present conformational energies for a molecular mechanical model (Parm99) developed for organic and biological molecules using the restrained electrostatic potential (RESP) approach to derive the partial charges.